Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study

BACKGROUND: In diabetes mellitus, during the last years, cancer became of equivalent importance as a cardiovascular disease in terms of mortality. In an earlier study, we have analyzed data of the National Health Insurance Fund (NHIF) of Hungary with regards all patients treated with sodium-glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Rokszin, György, Kiss, Zoltán, Sütő, Gábor, Kempler, Péter, Jermendy, György, Fábián, Ibolya, Szekanecz, Zoltán, Poór, Gyula, Wittmann, István, Molnár, Gergő Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581296/
https://www.ncbi.nlm.nih.gov/pubmed/34778040
http://dx.doi.org/10.3389/fonc.2021.725465

Ejemplares similares

Ejemplares similares